SCHEMBL7037437

SCHEMBL7037437

COC(=O)c1ccc(C[C@@H](CO)N(Cc2ccccc2)C[C@H](O)COc2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
LMNA P02545 1/20 0.52
GAA P10253 1/20 0.50
TSHR P16473 1/20 0.50
MAPT P10636 3/20 0.47
RAB9A P51151 1/20 0.47
POLB P06746 1/20 0.47
ADRB1 P08588 5/20 0.46
ADRB3 P13945 5/20 0.46
ADRB2 P07550 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
ABCB1 P08183 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538889 0.93 ADRB1 (0.49) ALDH1A1LMNAGAATSHRADRB1
SCHEMBL7246502 0.90 POLB (0.48) ALDH1A1LMNAGAATSHRMAPT
SCHEMBL6539381 0.85 ADRB1 (0.54) ALDH1A1LMNAMAPTRAB9AADRB1
SCHEMBL6538732 0.85 ADRB1 (0.50) LMNARAB9AADRB1ADRB3ADRB2
SCHEMBL6538563 0.84 ADRB1 (0.54) LMNARAB9AADRB1ADRB3ADRB2
SCHEMBL6540060 0.84 ADRB1 (0.48) LMNARAB9APOLBADRB1ADRB3
SCHEMBL6478257 0.84 POLB (0.50) ALDH1A1LMNAGAATSHRMAPT
SCHEMBL6538833 0.84 ADRB3 (0.61) ALDH1A1MAPTRAB9APOLBADRB1
SCHEMBL6539389 0.83 POLB (0.44) ALDH1A1LMNAGAATSHRMAPT
SCHEMBL7686428 0.83 ADRB1 (0.49) ALDH1A1LMNAGAATSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073846-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-04-17 US disclosed
EP-1292564-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-03-19 EP disclosed
WO-2001062705-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073846-A1 Aminoalcohol derivatives XDH, ADH1A, ADRB1 ALDH1A1 103/4885LMNA 724/4885GAA 4150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.